Literature DB >> 12592073

Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.

Rolf Hoffmann1.   

Abstract

Androgenetic alopecia (AGA) is the most common type of hair loss. The relatively strong concordance of the degree of baldness in fathers and sons is not consistent with a simple Mendelian trait, and a polygenic basis is considered to be most likely. So far, the predisposing genes for AGA are unknown and we do not understand the molecular steps involved in androgen-dependent beard growth versus androgen-dependent hair loss, but AGA can be defined as a dihydrotestosterone (DHT)-dependent process with continuous miniaturization of sensitive hair follicles. The type 2 5alpha-reductase plays a central role by the intrafollicular conversion of testosterone to DHT. However, due to the increasing knowledge in this field, we now know that there are many more steroidogenic enzymes involved in the onset and development of AGA, and this article shall provide a critical overview of recent discoveries. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592073     DOI: 10.1159/000068475

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

Review 1.  Visually scoring hirsutism.

Authors:  Bulent O Yildiz; Sheila Bolour; Keslie Woods; April Moore; Ricardo Azziz
Journal:  Hum Reprod Update       Date:  2010 Jan-Feb       Impact factor: 15.610

2.  Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function.

Authors:  Francesco Pallotti; Giulia Senofonte; Marianna Pelloni; Francesco Cargnelutti; Tania Carlini; Antonio F Radicioni; Alfredo Rossi; Andrea Lenzi; Donatella Paoli; Francesco Lombardo
Journal:  Endocrine       Date:  2020-02-12       Impact factor: 3.633

3.  [Androgenetic alopecia].

Authors:  R Hoffman
Journal:  Hautarzt       Date:  2004-01       Impact factor: 0.751

4.  The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study.

Authors:  Jae-Hong Kim; Sung Yul Lee; Hae-Jin Lee; Na-Young Yoon; Won-Soo Lee
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.